United Therapeutics Corporation ( UTHR) - Key Metrics
UTHR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $17.84 | $8.22 | $7.81 | $3.91 |
| 2025Q3 | $18.25 | $7.73 | $12.83 | $8.03 |
| 2025Q2 | $17.71 | $6.86 | $4.25 | $2.87 |
| 2025Q1 | $17.69 | $7.18 | $10.27 | $8.60 |
UTHR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 14.81 |
| 2025Q3 | ? | 13.55 |
| 2025Q2 | ? | 10.47 |
| 2025Q1 | ? | 10.74 |
UTHR Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 1.41% | ? |
| 2025Q4 | 0.80% | ? |
| 2025Q3 | 1.91% | ? |
| 2025Q2 | 1.00% | ? |
| 2025Q1 | 2.79% | ? |
UTHR
Price: $545.96
52 week price:
Earnings Per Share: 27.05 USD
P/E Ratio: 21.51
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 115651
Ebitda: 331.7 millionMarket Capitalization: 23.2 billion